Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"22,782 (9,559, 34,154)","58.6% (46.4%, 82.9%)","70.8% (55.3%, 83.1%)","17.4% (11.2%, 36.4%)","56.2% (44.4%, 80.7%)","20.5 (16.3, 29.0)","24.8 (19.4, 29.1)","6.1 (3.9, 12.7)","19.7 (15.5, 28.2)",,,,,
"(p=None, None), q=(None, None), c=0.500)","19,885 (8,717, 33,070)","67.7% (51.7%, 93.2%)","46.1% (29.0%, 68.2%)","9.6% (5.7%, 14.8%)","65.1% (49.2%, 91.8%)","23.7 (18.1, 32.6)","16.1 (10.2, 23.9)","3.3 (2.0, 5.2)","22.8 (17.2, 32.1)","-13.5% (-27.1%, 0.6%)","15.4% (4.7%, 24.4%)","-35.1% (-54.9%, -13.9%)","-39.8% (-70.9%, -14.1%)","15.8% (4.8%, 24.9%)"
"(p=None, None), q=(None, None), c=0.750)","20,056 (9,299, 31,782)","68.1% (52.9%, 92.7%)","45.1% (28.9%, 66.4%)","9.0% (5.6%, 14.5%)","65.7% (50.7%, 91.4%)","23.8 (18.5, 32.5)","15.8 (10.1, 23.2)","3.2 (2.0, 5.1)","23.0 (17.7, 32.0)","-12.2% (-25.0%, 6.1%)","16.2% (8.9%, 24.4%)","-36.4% (-56.1%, -17.2%)","-42.9% (-74.2%, -18.0%)","16.9% (9.7%, 25.5%)"
"(p=None, None), q=(None, None), c=1.000)","19,990 (9,778, 32,190)","69.1% (53.9%, 93.6%)","44.8% (28.6%, 65.6%)","8.7% (5.2%, 14.2%)","66.8% (51.7%, 92.4%)","24.2 (18.9, 32.8)","15.7 (10.0, 23.0)","3.0 (1.8, 5.0)","23.4 (18.1, 32.4)","-12.0% (-28.1%, 12.9%)","18.2% (9.8%, 28.6%)","-37.0% (-56.5%, -18.7%)","-45.5% (-74.4%, -17.6%)","18.9% (10.1%, 29.8%)"
